NCRA Training Link

Dear Wisconsin Cancer Reporters,

As part of getting ready for the transition from Collaborative Stage to directly-assigned clinical and pathologic Tumor, Nodes, Metastases (TNM) staging and SEER Summary Stage in 2015-2016, the National Cancer Registrars Association (NCRA) is providing free training. For those reporters that are new to cancer registry work and reporters that need a refresher, this is a great opportunity to receive training on the American Joint Committee on Cancer (AJCC) TNM coding and SEER summary stage.

While WCRS never stopped requiring SEER summary stage, these training sessions provide an excellent refresher and additional information since the requirement for benign brain tumor reporting began in 2004.

These training sessions are the educational modules that were presented in May at NCRA’s 2014 annual conference during the CDC National Program of Cancer Registries (NPCR) Education and Training Coordinators’ Workshop. They have been posted on the NCRA website. This link will direct you to the presentations, http://www.cancerregistryeducation.org/tnm-ss-resources .

Presentations include:
Results of the AJCC-NCRA Educational Needs Assessment
The National Transition to Directly Coded Stage
CDC-NPCR Transition to Directly Coded Staging: Overview of Transition Activities
CDC-NPCR Transition to Directly Coded Staging: General Rules SEER SS 2000
CDC-NPCR Transition to Directly Coded Staging: Guidelines for Assigning SS 2000
CDC-NPCR Transition to Directly Coded Staging: General Rules for AJCC
CDC-NPCR Transition to Directly Coded Staging: AJCC – Review of Four Cases

If you do not need CE hours, you can watch these presentations for free by clicking directly on the presentation icon. If you would like to purchase CE hours please fill out the viewing form that is available on ths NCRA website and mail payment and form to:

NCRA
Attn: Store/CCRE CEs
1330 Braddock Place Suite 520
Alexandria, VA 22314 USA

You can also find a link to the presentations on the WCRS website at http://www.dhs.wisconsin.gov/wcrs/reporterinfo/index.htm

Sincerely,

Laura Stephenson
QA Manager
Wisconsin Cancer Reporting System

Collaborative Staging Changes

August 23, 2013

After careful consideration, the American Joint Committee on Cancer AJCC), Centers for Disease Control and Prevention (CDC), the Commission on Cancer (CoC), and the National Cancer Institute (NCI) have determined that it is not feasible to continue support of Collaborative Staging beyond diagnosis year 2015. Beginning with cases diagnosed in 2016 support of Collaborative Stage will cease and CDC, CoC and NCI will transition to direct coding of the AJCC TNM staging. We believe that direct coding of AJCC along with the careful collection of clinically significant biomarkers and prognostic factors will provide our programs with a more precise and stable method for the collection of staging data that is positioned to keep pace with future medical advances. The Canadian Council of Cancer Registries (CCCR) is aware of the forthcoming changes and has started a process to determine how staging will continue in Canada.

2014 and 2015 will be a transition period for all of us. During this transition the Collaborative Stage v2.05 Data Collection System will be used. At the same time the AJCC, CDC, CoC, NCI and CCCR will devote resources and support for training and other activities to ensure the continued collection of high quality data. Training will focus on procedures for directly coding clinical and pathological AJCC T, N, and M and stage group, as well as identifying optimal methods to capture biomarkers and prognostic factors. Although planning for this transition is just beginning we will be depending on the surveillance community, in coordination with NAACCR and NCRA, for expertise and insights into effective training development and delivery; and the needed changes in reporting standards and software as we move forward. Together we will build new processes which will ensure the continued collection of high quality data to inform research based on more meaningful clinical information and improve our ability to support best practices for patient care.